Uncategorized - April 7, 2022
Elicera published scientific article describing the mechanism-of-action of iTANK
Elicera Therapeutics have announced the publication of a scientific article describing the mechanism-of-action of the company’s universal CAR T-cell enhancement technology platform iTANK in Nature Biomedical Engineering. Proof-of-concept data presented in the publication also indicate that the iTANK-platform is universally compatible with other CAR T-cell therapies, states the company in a press release. The iTANK-platform […]
Global report - March 25, 2022
NLS Insight: Circadian rhythms
This weekend most countries in Europe will spring forward one hour. We take a closer look upon how our inner clock regulates critical functions like behavior, hormone levels, sleep, body temperature and metabolism. Daylight Saving Time (DST) is not removed in 2022 despite the fact that the European Parliament voted to end daylight saving time […]
Uncategorized - March 21, 2022
Study reveals new genetic risk factors for migraine
The largest genetic study of migraine to date reveals new genetic risk factors. In the largest genome study of migraine yet, researchers have more than tripled the number of known genetic risk factors for migraine. Among the identified 123 genetic regions are two that contain target genes of recently developed migraine-specific drugs. The study involved […]
Uncategorized - March 16, 2022
New platform for automated cell type identification
Researchers at FIMM have developed a computational approach that can automatically identify various cell types based on single-cell RNA-sequencing data. The method has a huge potential for unbiased profiling of mixtures of cells, both for large-scale projects and samples derived from a single patient, states the researchers. It is not yet known how many different […]
Uncategorized - March 9, 2022
Asgard Therapeutics reaches major milestone
Asgard Therapeutics has reached an important milestone in the development of its lead gene therapy product, TrojanDC, a cancer immunotherapy based in cell reprogramming. Through research, the founders of the company have increased the efficiency of their reprogramming methodology approximately 190-fold, allowing efficient conversion of multiple human cell-types into dendritic cells (DCs) able to set […]
Uncategorized - March 4, 2022
Certain RNA molecules control the repair of damaged DNA in cancer cells
A new study from Karolinska Institutet shows how certain RNA molecules control the repair of damaged DNA in cancer cells, a discovery that could eventually give rise to better cancer treatments. New research demonstrates that RNA molecules have a much broader function than previously thought and can play a key role in the development of […]